Science Explorer Interactive view Map
Researcher · Novartis (United States) · United States

David Chandiwana

David Chandiwana publishes mostly in Pulmonary and Respiratory Medicine, Economics and Econometrics and Oncology, on topics such as Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.

ORCID 0000-0002-5651-564X OpenAlex
World rank
#1,244,503
of 1,633,909 ranked researchers
Rank in United States
#302,578
of 358,040
Works
20
Citations
19
Citations per work
1.0

What does David Chandiwana research?

Pulmonary and Respiratory Medicine: 27.8%Economics and Econometrics: 27.8%Oncology: 25.0%Cancer Research: 5.6%other fields: 13.8%28%top field
Pulmonary and Respiratory Medicine27.8%Economics and Econometrics27.8%Oncology25.0%Cancer Research5.6%other fields13.8%

Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.

  1. 1Pulmonary and Respiratory Medicine28% of their works
  2. 2Economics and Econometrics28% of their works
  3. 3Oncology25% of their works
  4. 4Cancer Research6% of their works
  5. 5Radiology, Nuclear Medicine and Imaging3% of their works
  6. 6Endocrinology, Diabetes and Metabolism3% of their works

Research topics

Which keywords describe David Chandiwana's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Quality of Life, Chemotherapy-Induced Peripheral Neuropathy, Cost of Care and Financial Toxicity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Breast Cancer142 topics
  2. Metastatic Breast Cancer142 topics
  3. CDK4/6 Inhibitors101 topic
  4. Palbociclib101 topic
  5. Quality of Life72 topics
  6. Chemotherapy-Induced Peripheral Neuropathy41 topic
  7. Cost of Care41 topic
  8. Financial Toxicity41 topic
  9. HER241 topic
  10. Taxanes41 topic
  11. Trastuzumab41 topic
  12. Cost-effectiveness Analysis31 topic
  13. Drug Development Costs31 topic
  14. Generic Drugs31 topic
  15. Health Utility Measures31 topic
  16. Breast Tumours21 topic
  17. Gene Expression21 topic
  18. Biosimilars11 topic
  19. Immunogenicity11 topic

Where does David Chandiwana work?

David Chandiwana's main affiliation in the publication record is Novartis (United States), United States.

How many publications and citations does David Chandiwana have?

Science Explorer counts 20 works and 19 citations for David Chandiwana, ranking #1,244,503 of 1,633,909 researchers worldwide on the composite score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.